Inhibikase Therapeutics (IKT) Assets (QoQ) (2021 - 2026)
Inhibikase Therapeutics (IKT) Assets (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Inhibikase Therapeutics | 407.51 Mn | 237.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.34% |
| Dec 31, 2025 | 127.66% |
| Sep 30, 2025 | -10.42% |
| Jun 30, 2025 | -5.76% |
| Mar 31, 2025 | -4.38% |
| Dec 31, 2024 | 2,152.75% |
| Sep 30, 2024 | -50.41% |
| Jun 30, 2024 | -20.25% |
| Mar 31, 2024 | -23.70% |
| Dec 31, 2023 | -18.87% |
| Sep 30, 2023 | -19.99% |
| Jun 30, 2023 | -20.65% |
| Mar 31, 2023 | 12.94% |
| Dec 31, 2022 | -12.75% |
| Sep 30, 2022 | -15.92% |
| Jun 30, 2022 | -11.45% |
| Mar 31, 2022 | -9.61% |
| Dec 31, 2021 | -7.41% |
| Sep 30, 2021 | -6.80% |
| Jun 30, 2021 | 314.48% |